London:
Real-globe information on the effectiveness of Oxford and AstraZeneca’s COVID-19 vaccine in older men and women from its rollout in Britain should really support inform selection creating in other nations, Oxford Vaccine Group Director Andrew Pollard mentioned on Tuesday.
Asked if other nations should really look at true globe information from Public Health England, Pollard mentioned: “I think that the scientific committees in each of these countries will be doing exactly that over the days ahead.”
“The strength of evidence that we’re now seeing… all of that is being accessed by scientific committees in different countries, and I’m sure will help support their decision making,” he told BBC radio.